Results 201 to 210 of about 4,565 (213)

Vaborbactam: Spectrum of Beta-Lactamase Inhibition and Impact of Resistance Mechanisms on Activity in Enterobacteriaceae

Antimicrobial Agents and Chemotherapy, 2017
Olga Lomovskaya, Scott J Hecker
exaly  

Meropenem-Vaborbactam Tested against Contemporary Gram-Negative Isolates Collected Worldwide during 2014, Including Carbapenem-Resistant, KPC-Producing, Multidrug-Resistant, and Extensively Drug-Resistant Enterobacteriaceae

Antimicrobial Agents and Chemotherapy, 2017
Mariana Castanheira, Michael D Huband
exaly  

Meropenem-Vaborbactam Resistance Selection, Resistance Prevention, and Molecular Mechanisms in Mutants of KPC-Producing Klebsiella pneumoniae

Antimicrobial Agents and Chemotherapy, 2017
Olga Lomovskaya
exaly  

Effect of Meropenem-Vaborbactam vs Piperacillin-Tazobactam on Clinical Cure or Improvement and Microbial Eradication in Complicated Urinary Tract Infection

JAMA - Journal of the American Medical Association, 2018
Tanaya Bhowmick, Symeon Metallidis, Jose Vazquez   +2 more
exaly  

Vaborbactam

RCSB Protein Data Bank
openaire   +1 more source

Ceftazidime/Avibactam, Meropenem/Vaborbactam, or Both? Clinical and Formulary Considerations

Clinical Infectious Diseases, 2019
Jason M Pogue, Robert A Bonomo
exaly  

Activity of Meropenem-Vaborbactam in Mouse Models of Infection Due to KPC-Producing Carbapenem-Resistant Enterobacteriaceae

Antimicrobial Agents and Chemotherapy, 2018
Mojgan Sabet, Olga Lomovskaya
exaly  

Cloxacillin/meropenem/vaborbactam

Reactions Weekly
openaire   +1 more source

Activity of Meropenem-Vaborbactam against Pseudomonas aeruginosa and Acinetobacter baumannii in a Neutropenic Mouse Thigh Infection Model

Antimicrobial Agents and Chemotherapy, 2019
Mojgan Sabet
exaly  

Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of Vaborbactam and Meropenem Alone and in Combination following Single and Multiple Doses in Healthy Adult Subjects

Antimicrobial Agents and Chemotherapy, 2018
exaly